Michael Hogan, MD
Vascular Surgery · Biloxi, MSNPI 1982691531
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,511 of the $9,702 with a category attached, or 67.1%. It is spread thinly across 34 manufacturers, the largest accounting for just 16.8%.
Across 134 payments — averaging $72.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$2K
- Angiodynamics, Inc.$2K
- Silk Road Medical, Inc.$2K
- Bard Peripheral Vascular, Inc.$1K
- Endologix LLC$1K
- Penumbra, Inc.$449
- plus $2K from 28 others
What the payments were for
- Travel & lodging$1,66317%
- Food & beverage$6,51167%
- Other$1,52816%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 32 | $1,629 |
| Angiodynamics, Inc. | 1 | $1,528 |
| Silk Road Medical, Inc. | 10 | $1,509 |
| Bard Peripheral Vascular, Inc. | 14 | $1,460 |
| Endologix LLC | 7 | $1,224 |
| Penumbra, Inc. | 7 | $449 |
| W. L. Gore & Associates, Inc. | 7 | $304 |
| Philips North America LLC | 3 | $247 |
| Veryan Medical Incorporated | 2 | $149 |
| Johnson & Johnson | 10 | $148 |
| Polynovo North America LLC | 2 | $146 |
| Boston Scientific | 5 | $135 |
| Venclose Inc. | 1 | $111 |
| Medtronic(2 entities) | 6 | $94 |
| Cardiovascular Systems Inc. | 3 | $76 |
| Kerecis Limited | 2 | $55 |
| Terumo Medical Corporation | 1 | $51 |
| Smith+Nephew | 3 | $46 |
| Baxter Healthcare | 1 | $45 |
| Cagent Vascular Inc | 1 | $29 |
| Biom'up France SAS | 1 | $27 |
| Lemaitre Vascular, Inc. | 3 | $26 |
| Davol Inc. | 1 | $26 |
| Abbott | 1 | $25 |
| Reflow Medical Inc | 1 | $22 |
| Bayer | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Dilon Technologies, Inc. | 1 | $19 |
| Cardiva Medical, Inc. | 1 | $18 |
| Stryker | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $13 |
| Bioventus LLC | 1 | $12 |
| Biocompatibles, Inc. | 1 | $12 |
| Medela LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$1,528
- ENROUTE Transcarotid Neuroprotection System$1,446
- PuraPly$1,110
- ENHANCE Transcarotid Peripheral Access Kit$1,038
- ENROUTE Transcarotid Stent System$914
- ENROUTE 0.014 Guidewire$914
- Alto Abdominal Stent Graft System$668
- ENROUTE Transcarotid Stent$412
- AFX$389
- Penumbra System$267
- Indigo System$131
- BioMimics 3D Vascular Stent System$125
- ENROUTE .014 Guidewire$124
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$120
- Turbo Elite$119
- Novosorb BTM$114
- EVRSF$111
How this compares
$9,702 in reported general payments places this provider in the 70th percentile of 39 vascular surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 37 | $33,110 |
| EliquisApixaban | 14 | $14,357 |
| ClopidogrelClopidogrel Bisulfate | 136 | $1,538 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $447 |
| Cilostazol | 23 | $350 |
| Ciprofloxacin Hcl | 12 | $199 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $159 |
| Clindamycin Hcl | 13 | $120 |
| Atorvastatin Calcium | 25 | $110 |
| Triamcinolone Acetonide | 17 | $71 |
| Tramadol Hcl | 32 | $62 |
| Prednisone | 21 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $148 | $33,11037 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 39 vascular surgery providers in Mississippi.
Other vascular surgery in Biloxi
- Peter NeglenFlowood$599K
- Seshadri RajuJackson$573K
- Rishi RoyOcean Springs$75K
- Danon Garrido Montes de OcaFlowood$63K
- Jacqueline MajorsSouthaven$49K
- Justin ManleyFlowood$30K
- Christian SchunnCleveland$30K
- Zachary BaldwinJackson$25K
- Henry KirkOxford$18K
- Jennifer DinningJackson$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.